"Orolingual bradykinin angioedema after tissue plasminogen activator in acute stroke – treatment with or without C1-esterase inhibitor"

2018 ◽  
Vol 81/114 (4) ◽  
pp. 478-480 ◽  
Author(s):  
Věra Špatenková ◽  
Denisa Šímová ◽  
Vladimír Beneš 3rd ◽  
Jaroslav Jedlička
Keyword(s):  
Acute Stroke ◽  
Plasminogen Activator ◽  
Tissue Plasminogen Activator ◽  
Stroke Treatment ◽  
C1 Esterase Inhibitor ◽  
Tissue Plasminogen ◽  
Acute Stroke Treatment ◽  
Esterase Inhibitor

Detection and Primary Care Management of Acute Stroke

2012 ◽  
Vol 5 (6) ◽  
pp. 325-331
Author(s):  
Sudharani Manapragada ◽  
Peter Wanklyn ◽  
Sean McDermott
Keyword(s):  
Primary Care ◽  
Acute Stroke ◽  
Plasminogen Activator ◽  
Tissue Plasminogen Activator ◽  
Stroke Unit ◽  
Care Management ◽  
Stroke Treatment ◽  
Hyperacute Stroke ◽  
Tissue Plasminogen ◽  
Primary Care Management

‘Time is brain’ is the basis of modern day hyperacute stroke treatment. It is important to recognize an acute stroke and arrange immediate admission to a hyperacute stroke unit (HASU) to facilitate investigation, stabilization and emergency therapy, such as thrombolysis with tissue plasminogen activator (t-PA).

Sign in / Sign up

Export Citation Format

Share Document